Praxis Launches Patient Recruitment Campaign for An Epilepsy Medical Research Study

Brentwood, TN — June 8, 2004 — Praxis, a company specializing in centralized patient recruitment for clinical research studies, is providing services to a major pharmaceutical company for a national medical research study. The study, which is currently underway, compares the overall usefulness of two FDA-approved formulations for the treatment of epilepsy. The formulations are used in treating partial seizures.

Praxis is providing a variety of services for the clinical trial, including research site location assistance, community awareness, direct marketing, research site tools, direct to patient materials, and program management. The comprehensive program speaks to emergency room doctors, general practitioners, radiologists, and other medical professionals treating patients who suffer from partial seizures. The Phase IV study is taking place in 75 sites across the United States. The recruitment period is expected to be five months.

Praxis, headquartered in Brentwood, TN, provides the pharmaceutical and biotech industries with a wide range of services for patient recruitment and retention for clinical trials including patient profiling, recruitment planning, centralized fulfillment, media relations, advertising, and program management. For more information, call Praxis at (615) 312-8207.

> Back to Press Release archive